ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours.
PET
neuroendocrine neoplasia
synoptic reporting
Journal
Journal of neuroendocrinology
ISSN: 1365-2826
Titre abrégé: J Neuroendocrinol
Pays: United States
ID NLM: 8913461
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
revised:
29
08
2021
received:
14
07
2021
accepted:
31
08
2021
pubmed:
21
10
2021
medline:
20
4
2022
entrez:
20
10
2021
Statut:
ppublish
Résumé
The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to improve the standard of care delivered to patients diagnosed with or suspected of having neuroendocrine neoplasia (NEN). At its annual Scientific Advisory Board Meeting in 2018, experts in imaging, pathology and clinical care of patients with NEN drafted guidance for the standardised reporting of diagnostic studies critical to the diagnosis, grading, staging and treatment of NEN. These included pathology, radiology, endoscopy and molecular imaging procedures. In an iterative process, a synoptic reporting template for molecular imaging procedures was developed to guide personalised therapies. Following pilot implementation and refinement within the ENETS Center of Excellence network, harmonisation with specialist imaging societies including the Society of Nuclear Medicine, European Association of Nuclear Medicine and the International Cancer Imaging Society will be pursued.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13040Informations de copyright
© 2021 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.
Références
Aide N , Lasnon C , Veit-Haibach P , Sera T , Sattler B , Boellaard R . EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. Eur J Nucl Med Mol Imaging. 2017;44(Suppl 1):17-31.
Renshaw AA , Mena-Allauca M , Gould EW , Sirintrapun SJ . Synoptic reporting: evidence-based review and future directions. JCO Clin Cancer Inform. 2018;2:1-9.
Sluijter CE , van Lonkhuijzen LRCW , van Slooten H-J , Nagtegaal ID , Overbeek LIH . The effects of implementing synoptic pathology reporting in cancer diagnosis: a systematic review. Virchows Arch. 2016;468(6):639-649.
Bozkurt MF , Virgolini I , Balogova S , et al. Guideline for PET/CT imaging of neuroendocrine neoplasms with. Eur J Nucl Med Mol Imaging. 2017;44(9):1588-1601.
Hicks RJ . How I read cancer imaging studies: the master class series. Cancer Imaging. 2016;16:8.
Hofman MS , Hicks RJ . How we read oncologic FDG PET/CT. Cancer Imaging. 2016;16(1):35.
Sundin A , Arnold R , Baudin E , et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging. Neuroendocrinology. 2017;105(3):212-244.
Wahl RL , Jacene H , Kasamon Y , Lodge MA . From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122S-150S.
Baker JA , Kornguth PJ , Floyd CE . Breast imaging reporting and data system standardized mammography lexicon: observer variability in lesion description. AJR Am J Roentgenol. 1996;166(4):773-778.
Elsayes KM , Kielar AZ , Chernyak V , et al. LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma. 2019;6:49-69.
Steiger P , Thoeny HC . Prostate MRI based on PI-RADS version 2: how we review and report. Cancer Imaging. 2016;16:9.
Werner RA , Bundschuh RA , Bundschuh L , et al. Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications. Ann Nucl Med. 2018;32(8):512-522.
Chan D , Pavlakis N , Schembri G , et al. Dual somatostatin receptor/FDG PET/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance. Theranostics. 2017;7(5):1149-1158.
Hicks RJ . Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy. Cancer Imaging. 2010;10:83 Spec no A:S83-91.
Garin E , Le Jeune F , Devillers A , et al. Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors. J Nucl Med. 2009;50(6):858-864.
Barrington SF , Mikhaeel NG , Kostakoglu L , et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32(27):3048-3058.
de Herder WW , Fazio N , O’Toole D . ENETS standardized (synoptic) reporting in neuroendocrine tumours. J Neuroendocrinol. 2022;34:e13054. https://doi.org/10.1111/jne.13054
van Velthuysen MF , Couvelard A , Rindi G , et al. ENETS standardized (synoptic) reporting for neuroendocrine tumour pathology. J Neuroendocrinol. 2022. https://doi.org/10.1111/jne.13100
Dromain C , Vullierme M-P , Hicks RJ , et al. ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours. J Neuroendocrinol. 2022;34:e13044. https://doi.org/10.1111/jne.13044
Borbath I , Pape U-F , Deprez PH , et al. ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors. J Neuroendocrinol. 2022;34:e13105. https://doi.org/10.1111/jne.13105
Hofland J , Lamarca A , Steeds R , et al. Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force). J Neuroendocrinol. 2022;34:e13060. https://doi.org/10.1111/jne.13060